Document Detail


Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
MedLine Citation:
PMID:  23303603     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Papanicolaou (Pap) smears have revolutionized the management of patients with cervical cancers by permitting the detection of early, surgically curable tumors and their precursors. In recent years, the traditional Pap smear has been replaced by a liquid-based method, which allows not only cytologic evaluation but also collection of DNA for detection of human papillomavirus, the causative agent of cervical cancer. We reasoned that this routinely collected DNA could be exploited to detect somatic mutations present in rare tumor cells that accumulate in the cervix once shed from endometrial or ovarian cancers. A panel of genes that are commonly mutated in endometrial and ovarian cancers was assembled with new whole-exome sequencing data from 22 endometrial cancers and previously published data on other tumor types. We used this panel to search for mutations in 24 endometrial and 22 ovarian cancers and identified mutations in all 46 samples. With a sensitive massively parallel sequencing method, we were able to identify the same mutations in the DNA from liquid Pap smear specimens in 100% of endometrial cancers (24 of 24) and in 41% of ovarian cancers (9 of 22). Prompted by these findings, we developed a sequence-based method to query mutations in 12 genes in a single liquid Pap smear specimen without previous knowledge of the tumor's genotype. When applied to 14 samples selected from the positive cases described above, the expected tumor-specific mutations were identified. These results demonstrate that DNA from most endometrial and a fraction of ovarian cancers can be detected in a standard liquid-based Pap smear specimen obtained during routine pelvic examination. Although improvements need to be made before applying this test in a routine clinical manner, it represents a promising step toward a broadly applicable screening methodology for the early detection of gynecologic malignancies.
Authors:
Isaac Kinde; Chetan Bettegowda; Yuxuan Wang; Jian Wu; Nishant Agrawal; Ie-Ming Shih; Robert Kurman; Fanny Dao; Douglas A Levine; Robert Giuntoli; Richard Roden; James R Eshleman; Jesus Paula Carvalho; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Related Documents :
7564383 - Rates of growth of human solid neoplasms: part i.
19098003 - Somatic mutations of erbb4: selective loss-of-function phenotype affecting signal trans...
20689513 - Deficient pms2, ercc1, ku86, ccoi in field defects during progression to colon cancer.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Science translational medicine     Volume:  5     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-10     Completed Date:  2013-06-11     Revised Date:  2013-09-03    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  167ra4     Citation Subset:  IM    
Affiliation:
The Ludwig Center for Cancer Genetics and Therapeutics, The Swim Across America Laboratory at Johns Hopkins, Baltimore, MD 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
DNA, Neoplasm / analysis*,  genetics
Endometrial Neoplasms / diagnosis*,  genetics
Female
Humans
Mutation
Ovarian Neoplasms / diagnosis*,  genetics
Vaginal Smears*
Grant Support
ID/Acronym/Agency:
CA062924/CA/NCI NIH HHS; CA129825/CA/NCI NIH HHS; CA43460/CA/NCI NIH HHS; N01-CN-43309/CN/NCI NIH HHS; P50 CA062924/CA/NCI NIH HHS; P50 CA098252/CA/NCI NIH HHS; R01 CA129825/CA/NCI NIH HHS; R37 CA043460/CA/NCI NIH HHS; //Howard Hughes Medical Institute
Chemical
Reg. No./Substance:
0/DNA, Neoplasm
Comments/Corrections
Comment In:
Sci Transl Med. 2013 Jan 9;5(167):167ps1   [PMID:  23303602 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Repurposing the Pap smear: one step closer to gynecologic cancer screening.
Next Document:  Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactiv...